Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | ||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |||
| Abdominal pain | x | ||||||
| Anxiety | x | ||||||
| Arrhythmia | x | ||||||
| Asthenia | x | ||||||
| Cellulitis | x | x | |||||
| Confusional state | x | ||||||
| Dyspnoea | x | ||||||
| Rash | x | ||||||
| Extravasation | x | x | |||||
| Fatigue | x | ||||||
| Flatulence | x | ||||||
| Hyperkalaemia | x | x | x | ||||
| Hypernatraemia | x | ||||||
| Irritability | x | ||||||
| Nausea | x | x | x | ||||
| Necrosis | x | x | |||||
| Numbness | x | ||||||
| Tetany | x | ||||||
| Ulcer | x | x | |||||
| Vomiting | x | x | x | ||||
| Abdominal discomfort | x | x | |||||
| Warmth | x | x | |||||
| Tingling sensation | x | ||||||
| Gastrointestinal tract irritation | x | x | |||||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |